181 related articles for article (PubMed ID: 30243646)
1. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
Wee Y; Wang T; Liu Y; Li X; Zhao M
Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
[TBL] [Abstract][Full Text] [Related]
2. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
3. Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types.
Zhao M; Liu Y; Qu H
Oncotarget; 2016 Apr; 7(17):24688-99. PubMed ID: 27029057
[TBL] [Abstract][Full Text] [Related]
4. Concordance between somatic copy number loss and down-regulated expression: A pan-cancer study of cancer predisposition genes.
Wei R; Zhao M; Zheng CH; Zhao M; Xia J
Sci Rep; 2016 Dec; 6():37358. PubMed ID: 27929028
[TBL] [Abstract][Full Text] [Related]
5. Recurrent copy number gains drive PKCĪ¹ expression and PKCĪ¹-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
6. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
Gene; 2019 May; 697():57-66. PubMed ID: 30796966
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel prognosis-related genes associated with cancer using integrative network analysis.
Wee Y; Liu Y; Lu J; Li X; Zhao M
Sci Rep; 2018 Feb; 8(1):3233. PubMed ID: 29459674
[TBL] [Abstract][Full Text] [Related]
8. Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
Zhang L; Yuan Y; Lu KH; Zhang L
BMC Bioinformatics; 2016 May; 17(1):222. PubMed ID: 27230211
[TBL] [Abstract][Full Text] [Related]
9. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
Fields AP; Justilien V; Murray NR
Adv Biol Regul; 2016 Jan; 60():47-63. PubMed ID: 26754874
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
11. Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.
Yu CC; Qiu W; Juang CS; Mansukhani MM; Halmos B; Su GH
Cancer Lett; 2017 Jan; 384():86-93. PubMed ID: 27725226
[TBL] [Abstract][Full Text] [Related]
12. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
13. Copy number variation is highly correlated with differential gene expression: a pan-cancer study.
Shao X; Lv N; Liao J; Long J; Xue R; Ai N; Xu D; Fan X
BMC Med Genet; 2019 Nov; 20(1):175. PubMed ID: 31706287
[TBL] [Abstract][Full Text] [Related]
14. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
16. CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testing.
Innes J; Reali L; Clayton-Smith J; Hall G; Lim DH; Burghel GJ; French K; Khan U; Walker D; Lalloo F; Evans DGR; McMullan D; Maher ER; Woodward ER
J Med Genet; 2018 Feb; 55(2):89-96. PubMed ID: 28918392
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of DNA repair genes in cancer.
Chae YK; Anker JF; Carneiro BA; Chandra S; Kaplan J; Kalyan A; Santa-Maria CA; Platanias LC; Giles FJ
Oncotarget; 2016 Apr; 7(17):23312-21. PubMed ID: 27004405
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of genomic and transcriptomic alterations of
Fessart D; Villamor I; Chevet E; Delom F; Robert J
Open Biol; 2022 Jul; 12(7):220068. PubMed ID: 35857928
[TBL] [Abstract][Full Text] [Related]
19. Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells.
Soh J; Okumura N; Lockwood WW; Yamamoto H; Shigematsu H; Zhang W; Chari R; Shames DS; Tang X; MacAulay C; Varella-Garcia M; Vooder T; Wistuba II; Lam S; Brekken R; Toyooka S; Minna JD; Lam WL; Gazdar AF
PLoS One; 2009 Oct; 4(10):e7464. PubMed ID: 19826477
[TBL] [Abstract][Full Text] [Related]
20. CCG: an integrative resource of cancer protein-coding genes and long noncoding RNAs.
Liu M; Yang YT; Xu G; Tan C; Lu ZJ
Discov Med; 2016 Dec; 22(123):351-359. PubMed ID: 28147217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
